title: Branded prescription drug fee. Final regulations, temporary regulations, and removal of temporary regulations.
abstract: This document contains final regulations that provide guidance on the annual fee imposed on covered entities engaged in the business of manufacturing or importing branded prescription drugs. This fee was enacted by section 9008 of the Patient Protection and Affordable Care Act, as amended by section 1404 of the Health Care and Education Reconciliation Act of 2010. This document also withdraws the Branded Prescription Drug Fee temporary regulations and contains new temporary regulations regarding the definition of controlled group that apply beginning on January 1, 2015. The final regulations and the new temporary regulations affect persons engaged in the business of manufacturing or importing certain branded prescription drugs. The text of the temporary regulations in this document also serves as the text of proposed regulations set forth in a notice of proposed rulemaking (REG-123286-14) on this subject in the Proposed Rules section in this issue of the Federal Register.
mesh_terms: D003132:Commerce / Q000191:economics*; D004345:Drug Industry / Q000191:economics*; D005249:Fees and Charges / Q000331:legislation & jurisprudence*; D006801:Humans; D008484:Medicaid / Q000191:economics; D006278:Medicare / Q000191:economics; D058991:Patient Protection and Affordable Care Act; D055553:Prescription Drugs / Q000191:economics*; D014481:United States; D059030:United States Department of Defense / Q000191:economics; D014493:United States Department of Veterans Affairs / Q000191:economics
chemical_list: D055553:Prescription Drugs